Day 1 :
Chinese University of Hong Kong, Hong Kong
Time : 09:30 AM to 10:30 AM
Professor LEUNG Ping Chung, OBE, JP, Hon DSSc, DSC, MBBS, MS, FRACS, FRCS(Edin), FHKCOS, FHKAM(Orth); is Emeritus Professor of Orthopaedics & Traumatology, Faculty of Medicine; Director of Centre for Clinical Trials on Chinese Medicine, Institute of Chinese Medicine. His research areas including Orthopaedics, Osteoporosis, Microsurgery, Public Health, Traditional Chinese Medicine and General Education. He is also the author of over 800 scientific manuscripts in journals and 27 books. Professor Leung has been appointed as editor of 11 International Journals since 1982. He is trying hard to develop a research methodology basing on modern clinical science requirements, to modernize on Traditional Chinese medicine. Currently he is working on projects related to aging and neurodegeneration, which initiated his enthusiasm searching for wisdom from other well-established traditional medicine regions in the Middle East and South Asia.
Nutraceuticals could be interpreted as nutritional supplements any food substance that is good for health from dairy products to protein or fruit concentrates. Nutraceuticals could be more specific with clear target groups and special claims. China is moving towards that direction. Its State FDA since 2015 has issued a series of guideline for the development of nutritional supplements with special medicinal purposes and contents. Three areas are given immediate priorities viz. infants, lactating mothers and elderlies. Proper clinical trials are recommended. The Institute of Chinese Medicine at Chinese University of Hong Kong has been seriously developing medicinal supplements since year 2000. It has followed the evidence-based approach: From quality assurance, safety, bioactivity confirmations to proper clinical trials. Classical popular complex herbal formulations have been modified into simple combinations to form effective, medicinal supplement to support allopathic treatment of special conditions. The choice of herbs is guided by the pathological processes involved in particular disease entities. Examples of medicinal supplements developed for cancer and cardiovascular treatment will be given to illustrate the principle and procedures involved.
Sungkyunkwan University, South Korea
Time : 10:30 AM to 11:30 AM
Dr. Cho is a Professor at Sungkyunkwan University. His research areas are inflammatory and cancer signaling and development of anti-inflammatory and anti-cancer remedy from natural resources. His current research interests are to understand oncogene-related signaling cascade in cancer and inflammatory cells and figure out the molecular mechanism of anti-inflammatory and anti-cancer actions of naturally-occurring components. He is working as Editor-in-Chief of Journal of Ginseng Research (IF = 4.0) and a director of Research Institute of Biomolecule control sponsored by National Research Foundation Korea. He received a B.Sc. in Genetic Engineering from Sungkyunkwan University and M.Sc. (Genetic Engineering, Sungkyunkwan University) and Ph.D. (Molecular Immunology) from University College London in 2001. After his Ph.D., he worked as a postdoctoral fellow in Washington University. Before his moving to Sungkyunkwan University, Dr. Cho was an assistant and associate professor of Kangwon National University for 8 years from 2003. He has published 400 peer-reviewed papers and 150 registered and applied patents.
Ginseng is ethno-pharmacologically valuable herbal plant in Korea, China and Japan as well as North America. It has been reported to display a lot of pharmacological activities including anti-oxidative, anti-stress, anti-cancer, anti-inflammatory, anti-diabetic and anti-obesity effects. Ginsenosides or ginseng saponins and acid polysaccharides are major principles showing ginseng’s biological activities. By numerous studies immunoregulatory mechanism of ginseng and its active ingredients at the molecular levels has been elucidated. Thus, macrophages and NK cells are known as representative target cells in the regulation of immune responses by ginseng acid polysaccharides were components to activate macrophage and NK cell-mediated innate immune responses. Ginsenoside (G)-Rb1, G-Rc and G-Rd are found to suppress inflammatory responses by suppressing NF-kB and AP-1 pathways. Furthermore compound K, a metabolite of Ginseng saponins, stimulated functionality of macrophages by enhancement of transcriptional activation under normal conditions, whereas this compound displayed anti-inflammatory activity during LPS treatment. Target of compound K seems to be considered as AKT1. Therefore, these results strongly suggest that Korean ginseng is capable of normalizing suppressed or enhanced immune responses by modulation of specific target proteins such as AKT1 linked to the activation of NF-kB and AP-1 pathway.
China Medical University, Taiwan
Keynote: Growth inhibition of acute myeloid leukemia cells by Chinese herbal medicine Ganoderma tsugae via mitochondria/caspase activation pathway
Time : 12:00 PM to 01:00 PM
Ming-Ching Kao has completed his PhD from Louisiana State University, Baton Rouge, USA. He was the Chairman/Director of Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan. Currently, he is a Professor of the Department of Biological Science and Technology, China Medical University, Taiwan. He has published more than 89 papers in reputed journals and has been serving as an Editorial Board Member of Journal of Traditional and Complementary Medicine. His research interests include anti-cancer traditional medicine and gene therapy.
Ganoderma (also called Lingzhi or Reishi) belongs to a Chinese Herbal Medicine (CHM) and has been widely used as a dietary supplement and for preventing or curing a wide variety of diseases including cancer in Asian countries. Ganoderma tsugae (GT), one of the major species of Lingzhi cultivated in Taiwan has been reported that GT Ethanol Extract (GTEE) has growth inhibition effects on human cancer cells, including breast cancer, ovarian cancer, colorectal cancer, epidermoid carcinoma, hepatoma and lung adenocarcinoma. However, little is known about the effects of GTEE on Acute Myeloid Leukemia (AML). The purpose of this study is to unravel the anti-leukemia effects of GTEE and their relevant molecular mechanisms. By using CCK-8 and trypan blue assays, we found that GTEE had potential growth inhibition effect on human leukemia THP-1 cells. Furthermore, GTEE induced human THP-1 cell apoptosis through the mitochondria/caspase activation pathway in a dose-dependent manner. Subsequently, GTEE may inhibit survival of human leukemia THP-1 cells via modulation of expression and activation of AKT pathway. Taken together, this study suggests that GTEE may be beneficial to human healthcare and be an adjuvant therapeutic agent for the treatment of human leukemia.
Jean-Marie poffe completed his pharmacist degree in 1976 at UCL (Brussels). In 1977, he obtained his certificate of pharmacist specialized in clinical bacteriology. For 20 years he has practiced the profession of pharmacist in his own pharmacy. Later he did specialization in nutrition and micro-nutrition and from 2005, he had started his consultations.
We will start with a histological reminder of the Gastrointestinal tract (GIT) membrane and its constituents. We will then talk about the GIT as immunologic membrane = GALT. We will review the consequences of so-called diseases of civilization. (intolerances, allergies, MIC). Then we will talk about the immune response, the differentiation of lymphocytes, the secretion of IgA, auto-illunes, the interest of pre-biotics and pro-biotics, the existing relationship between pro-biotics and immunity. It is concluded as the vital importance of the good functioning of the GIT for the well-being of patients.
Institute of Chemical Technology, India
Title: Synthesis of blue dye from loganin: Its application in dyeing, ultraviolet protection of proteinous fabric and docking studies
Time : 02:30 PM to 03:00 PM
Sapna P Patil has completed her PhD from Institute of Chemical Technology, Mumbai. She has worked on Iridoids topic, on its extraction, isolation and chemical derivatization. She has two years of pharma industrial experience.
Iridoids are secondary metabolites produced by plants and some animals. These iridoids give colored pigments or dyes by a simple chemical process in the presence of primary amine, amino acids and protein-based substrate. The aim of the present work is mainly to study the blue colored dye, synthesized from an iridoid glycoside loganin from Strychnos nux-vomica and explore its application in textile industry. Another aim is to carry out Computer-Aided Drug Design (CADD) studies to determine the blue dye interaction with silk monomeric units. Isolated white loganin was converted to blue dye by one step chemo enzymatic reaction, wherein loganin was transformed to aglycone, loganetin which was further allowed to react with amino acids generating a blue colorant. The colorant was further studied for its application to dye proteinous fabric like wool and silk. Color strength, fastness properties and Ultraviolet protection factor were evaluated. Mordanting studies were carried out using three different mordants. The fabric was also subjected to pre-mordanting, meta-mordanting and post-mordanting studies Treated fabrics showed adequate wash, light and rubbing properties with and without mordanting. The treated silk and wool fabric showed good to very good ultraviolet protection property with mordanted fabric. The loganin, its aglycone and blue dye structures were subjected to molecular docking using Glide and SiteMap software.
King Saud University Medical City, Saudi Arabia
Time : 03: 00 PM to 03:30 PM
Hadeel Saud Alshubaili has graduated from King Saud University, Saudi Arabia. She is the Dietitian of Metabolic and Genetics. She is certified Spinning Trainer and a Gym Instructor, she has participated in many conferences locally and internationally as a speaker.
Good nutrition will help the athletes train hard, recover quickly and adapt more effectively with less of illness or injury. Nutritional strategies need to be adopted before, during and after training to help maximize performance. Water accounts for approximately 60% of the average person’s body weight and it varies with muscle mass, age & hydration status. Fluid loss of as little as 2% can cause early fatigue, impair performance, increase cardiac stress and increase risk of heat illness. Proper hydration is necessary before, during and after the training.
Type of diet followed by the female athletes according to life style and goals are: keto diet , low carb diet , vegan , vegetarian and paleo diet. Proteins, amino acids supplement required by the female athletes such as whey protein, casein during the pre or post workout can be covered by regular food.
The benefits of physical activity (sports) along with proper nutrition in women’s health are: T2DM (Type 2 diabetes mellitus), osteoporosis, mental health and cardiac health.